Botox 200 unit vials

Ended Awarded Last action

Contract number
SPE2DR26FQTA1
Awardee
Awarding agency
Obligated
$39,610

Award facts

Contract value 100% obligated
$39,609.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $39,609.60 delivery order to DMS Pharmaceutical Group Inc. on March 13, 2026, for BOTOX 200 unit vials, with ultimate completion on April 3, 2026.

The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a firm fixed-price indefinite delivery contract authorizing DLA to issue delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL.

Quick answers

Who was awarded contract SPE2DR26FQTA1?

SPE2DR26FQTA1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 13, 2026.

How much is contract SPE2DR26FQTA1 worth?

The government has obligated $39,610 on SPE2DR26FQTA1.

Is contract SPE2DR26FQTA1 an order under another contract?

Yes. SPE2DR26FQTA1 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.

Was contract SPE2DR26FQTA1 competed?

The extent of competition for SPE2DR26FQTA1 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award